HCA Healthcare, Inc. (NYSE:HCA) Shares Sold by Geode Capital Management LLC

Geode Capital Management LLC trimmed its stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 2.1% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 3,820,736 shares of the company's stock after selling 81,109 shares during the period. Geode Capital Management LLC owned 1.51% of HCA Healthcare worth $1,546,584,000 as of its most recent SEC filing.

Several other hedge funds have also bought and sold shares of HCA. FMR LLC raised its stake in HCA Healthcare by 322.3% during the 3rd quarter. FMR LLC now owns 3,141,769 shares of the company's stock valued at $1,276,909,000 after buying an additional 2,397,883 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in HCA Healthcare by 2.8% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,487,367 shares of the company's stock worth $604,511,000 after acquiring an additional 41,190 shares during the last quarter. Janus Henderson Group PLC grew its position in HCA Healthcare by 12.0% in the third quarter. Janus Henderson Group PLC now owns 1,339,638 shares of the company's stock worth $544,467,000 after acquiring an additional 143,995 shares in the last quarter. Darsana Capital Partners LP boosted its stake in shares of HCA Healthcare by 53.3% during the 2nd quarter. Darsana Capital Partners LP now owns 1,150,000 shares of the company's stock worth $369,472,000 after purchasing an additional 400,000 shares during the period. Finally, TD Asset Management Inc increased its stake in HCA Healthcare by 2.7% in the second quarter. TD Asset Management Inc now owns 741,130 shares of the company's stock worth $238,110,000 after purchasing an additional 19,812 shares during the period. Institutional investors own 62.73% of the company's stock.

Wall Street Analyst Weigh In

HCA has been the subject of several research reports. StockNews.com cut HCA Healthcare from a "strong-buy" rating to a "buy" rating in a report on Monday, November 4th. Royal Bank of Canada boosted their price objective on shares of HCA Healthcare from $378.00 to $405.00 and gave the stock an "outperform" rating in a research note on Friday, August 23rd. Morgan Stanley initiated coverage on HCA Healthcare in a research report on Tuesday, September 3rd. They set an "equal weight" rating and a $427.00 price objective on the stock. Wolfe Research raised HCA Healthcare to a "strong-buy" rating in a research report on Thursday, August 29th. Finally, Truist Financial increased their price target on HCA Healthcare from $390.00 to $430.00 and gave the company a "buy" rating in a research note on Monday, August 19th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating, twelve have assigned a buy rating and two have issued a strong buy rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $380.29.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, SVP Phillip G. Billington sold 3,897 shares of the business's stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the sale, the senior vice president now directly owns 52,702 shares in the company, valued at approximately $18,445,700. The trade was a 6.89 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Michael S. Cuffe sold 8,358 shares of the company's stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total value of $3,221,340.36. Following the completion of the sale, the executive vice president now directly owns 29,678 shares in the company, valued at $11,438,494.76. This trade represents a 21.97 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 15,155 shares of company stock valued at $5,608,990 in the last 90 days. Company insiders own 1.70% of the company's stock.

HCA Healthcare Trading Down 0.5 %

Shares of HCA traded down $1.56 during midday trading on Wednesday, reaching $315.23. The company had a trading volume of 882,105 shares, compared to its average volume of 1,201,990. The stock has a market cap of $79.85 billion, a PE ratio of 14.22, a price-to-earnings-growth ratio of 1.23 and a beta of 1.63. HCA Healthcare, Inc. has a 1-year low of $260.79 and a 1-year high of $417.14. The company has a quick ratio of 1.00, a current ratio of 1.12 and a debt-to-equity ratio of 48.71. The firm has a 50 day simple moving average of $360.32 and a 200-day simple moving average of $358.90.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Friday, December 13th will be issued a $0.66 dividend. The ex-dividend date is Friday, December 13th. This represents a $2.64 annualized dividend and a dividend yield of 0.84%. HCA Healthcare's dividend payout ratio is presently 11.85%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.